Novo Nordisk's Rybelsus (oral semaglutide) received an updated label from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) in a significant regulatory victory, based on evidence of cardiovascular benefit from...
Swiss drugmaker Novartis suffered a major blow as the Indian Patent Office (IPO) stripped off the patent for its heart failure drug Vymada (Entresto internationally) citing it as a lack of novelty and inventive step.
.jpeg "Meril Launches Mizzo Endo 4000 Robotic Surgery System")
Meril which is a medical device company from India that is one of the best in the world, has introduced the Mizzo Endo 4000
At the Confederation of Indian Industry's (CII) Hospital Tech 2025 conference, Zen Multispeciality Hospital received the esteemed CII WR Health Innovation Award 2025. The hospital's exceptional dedication to academic achievement and healthcare
Vivekananda Yoga University (VaYU), the first yoga university outside of India devoted to graduate education and research in yoga, and Apollo AyurVAID, a trailblazing chain of next-generation, precision Ayurvedic hospitals and a member of the Apollo
The All India Institute of Medical Sciences (AIIMS), New Delhi, has made history in surgical education with the launch of the da Vinci Surgical Robot at its Skills, E-Learning and Telemedicine (SET) Facility. This has made AIIMS the first...
Fermenta Biotech Limited, the top producer of high-quality APIs, intermediates, and nutritional premixes for international markets in India, declared that its discovery of a plant-based vitamin D3 has been officially given a patent by the Indian
Delhi became the latest Indian states to intensify its crackdowns on counterfeit medicines by forming a special committee under the health department, officials confirmed today. The action follows enhanced concerns over the sale of counterfeit...
AstraZeneca has announced today landmark data from the Phase III FLAURA2 trial, demonstrating that its targeted therapy, Tagrisso (osimertinib), plus pemetrexed and platinum-based chemotherapy, achieved the longest overall survival reported in any...
AstraZeneca has received a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) for a protocol being amended to widen the ongoing global clinical trial
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")